Shelton Capital Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,813
| Closed | -$312K | – | 713 |
|
|
2022
Q1 | $312K | Hold |
1,813
| – | – | 0.01% | 516 |
|
|
2021
Q4 | $293K | Hold |
1,813
| – | – | 0.01% | 568 |
|
|
2021
Q3 | $270K | Hold |
1,813
| – | – | 0.01% | 605 |
|
|
2021
Q2 | $444K | Hold |
1,813
| – | – | 0.02% | 403 |
|
|
2021
Q1 | $480K | Hold |
1,813
| – | – | 0.02% | 397 |
|
|
2020
Q4 | $532K | Sell |
1,813
-66
| -4% | -$19.4K | 0.02% | 328 |
|
|
2020
Q3 | $444K | Hold |
1,879
| – | – | 0.02% | 447 |
|
|
2020
Q2 | $373K | Sell |
1,879
-97
| -5% | -$19.3K | 0.02% | 374 |
|
|
2020
Q1 | $363K | Hold |
1,976
| – | – | 0.03% | 342 |
|
|
2019
Q4 | $330K | Hold |
1,976
| – | – | 0.02% | 479 |
|
|
2019
Q3 | $259K | Hold |
1,976
| – | – | 0.02% | 598 |
|
|
2019
Q2 | $240K | Buy |
+1,976
| New | +$240K | 0.01% | 666 |
|
|
2019
Q1 | – | Sell |
-2,871
| Closed | -$336K | – | 829 |
|
|
2018
Q4 | $336K | Hold |
2,871
| – | – | 0.02% | 422 |
|
|
2018
Q3 | $359K | Buy |
2,871
+100
| +4% | +$12.5K | 0.02% | 493 |
|
|
2018
Q2 | $237K | Buy |
+2,771
| New | +$237K | 0.01% | 704 |
|